Jung-Im Shin

35PUBLICATIONS
67CO-AUTHORS
PharmacogenomicsMolecular targetsMedical biochemistry - carbohydratesCross-sectional analysisMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Mar 20, 2026
Glucagon-like peptide-1 receptor agonists for major cardiovascular and kidney outcomes in type 1 diabetes.

Yunwen Xu, Natalie Daya Malek, Alexander R Chang

|Jan 02, 2026
Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex.

Changyuan Yang, Petra Denig, Lynne Chepulis

|Dec 16, 2025
A Target Trial Emulation Study of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Combination Therapy in Preventing Kidney Failure in Type 2 Diabetes.

Matthew F Blum, Sneha Mehta, Aditya Surapaneni

|Jun 12, 2025
Detecting Hyperglycemia Using Biomarkers Versus Continuous Glucose Monitoring.

Natalie Rula Daya, Michael Fang, Jung-Im Shin

|Apr 09, 2025
Association of Patient Cost Sharing With Adherence to GLP-1RA and Adverse Health Outcomes.

Donglan Zhang, Nihan Gencerliler, Amrita Mukhopadhyay

Pageof 6